Possible role of edotecarin, a novel topoisomerase I inhibitor, in therapy-related myelodysplastic syndrome.
Article Details
- CitationCopy to clipboard
Carvajal RD, Ilson DH, Noy A
Possible role of edotecarin, a novel topoisomerase I inhibitor, in therapy-related myelodysplastic syndrome.
Leuk Lymphoma. 2007 Jan;48(1):192-4.
- PubMed ID
- 17325867 [ View in PubMed]
- Abstract
Not Available
DrugBank Data that Cites this Article
- Drug Targets
Drug Target Kind Organism Pharmacological Action Actions Edotecarin DNA topoisomerase 1 Protein Humans UnknownNot Available Details